|
1
|
McNicholas WT: Chronic obstructive
pulmonary disease and obstructive sleep apnea: Overlaps in
pathophysiology, systemic inflammation and cardiovascular disease.
Am J Respir Crit Care Med. 180:692–700. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ioachimescu OC and Teodorescu M:
Integrating the overlap of obstructive lung disease and obstructive
sleep apnoea: OLDOSA syndrome. Respirology. 18:421–431. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wouters EF: Local and systemic
inflammation in chronic obstructive pulmonary disease. Proc Am
Thorac Soc. 2:26–33. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Thunström E, Glantz H, Fu M,
Yucel-Lindberg T, Petzold M, Lindberg K and Peker Y: Increased
inflammatory activity in nonobese patients with coronary artery
disease and obstructive sleep apnea. Sleep. 38:463–471. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gonzalez NC and Wood JG: Alveolar
hypoxia-induced systemic inflammation: What low PO (2) does and
does not do. Adv Exp Med Biol. 662:27–32. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fuhrmann V, Kneidinger N, Herkner H, Heinz
G, Nikfardjam M, Bojic A, Schellongowski P, Angermayr B, Kitzberger
R, Warszawska J, et al: Hypoxic hepatitis: Underlying conditions
and risk factors for mortality in critically ill patients.
Intensive Care Med. 35:1397–1405. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
van Eeden SF and Sin DD: Chronic
obstructive pulmonary disease: A chronic systemic inflammatory
disease. Respiration. 75:224–238. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dopp JM, Moran JJ, Abel NJ, Wiegert NA,
Cowgill JB, Olson EB and Sims JJ: Influence of intermittent hypoxia
on myocardial and hepatic P-glycoprotein expression in a rodent
model. Pharmacotherapy. 29:365–372. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wrighton SA, Schuetz EG, Thummel KE, Shen
DD, Korzekwa KR and Watkins PB: The human CYP3A subfamily:
Practical considerations. Drug Metab Rev. 32:339–361. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pan X, Wang P, Hu N, Liu L, Liu X, Xie L
and Wang G: A physiologically based pharmacokinetic model
characterizing mechanism-based inhibition of CYP1A2 for predicting
theophylline/antofloxacin interaction in both rats and humans. Drug
Metab Pharmacokinet. 26:387–398. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Wang Y, Yang Y, Luo Y and Chen P:
Effect of chronic intermittent hypoxia on the expression of
fractalkine in rat liver. Zhong Nan Da Xue Xue Bao Yi Xue Ban.
38:984–990. 2013.(In Chinese). PubMed/NCBI
|
|
12
|
Feng J, Wang QS, Chiang A and Chen BY: The
effects of sleep hypoxia on coagulant factors and hepatic
inflammation in emphysematous rats. PLoS One. 5:e132012010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zanger UM and Schwab M: Cytochrome P450
enzymes in drug metabolism: Regulation of gene expression, enzyme
activities, and impact of genetic variation. Pharmacol Ther.
138:103–141. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Assenat E, Gerbal-Chaloin S, Larrey D,
Saric J, Fabre JM, Maurel P, Vilarem MJ and Pascussi JM:
Interleukin 1beta inhibits CAR-induced expression of hepatic genes
involved in drug and bilirubin clearance. Hepatology. 40:951–960.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Widén C, Gustafsson JA and Wikström AC:
Cytosolic glucocorticoid receptor interaction with nuclear
factor-kappa B proteins in rat liver cells. Biochem J. 373:211–220.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Magalang UJ, Cruff JP, Rajappan R, Hunter
MG, Patel T, Marsh CB, Raman SV and Parinandi NL: Intermittent
hypoxia suppresses adiponectin secretion by adipocytes. Exp Clin
Endocrinol Diabetes. 117:129–134. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Feng J, Chiang AA, Wu Q, Chen BY, Cui LY,
Liang DC, Zhang ZL and Yao W: Sleep-related hypoxemia aggravates
systematic inflammation in emphysematous rats. Chin Med J (Engl).
123:2392–2399. 2010.PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Slaviero KA, Clarke SJ and Rivory LP:
Inflammatory response: An unrecognised source of variability in the
pharmacokinetics and pharmacodynamics of cancer chemotherapy.
Lancet Oncol. 4:224–232. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Aitken AE, Richardson TA and Morgan ET:
Regulation of drug-metabolizing enzymes and transporters in
inflammation. Annu Rev Pharmacol Toxicol. 46:123–149. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ivanenkov YA, Balakin KV and Lavrovsky Y:
Small molecule inhibitors of NF-kB and JAK/STAT signal transduction
pathways as promising anti-inflammatory therapeutics. Mini Rev Med
Chem. 11:55–78. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sandireddy R, Yerra VG, Areti A,
Komirishetty P and Kumar A: Neuroinflammation and oxidative stress
in diabetic neuropathy: Futuristic strategies based on these
targets. Int J Endocrinol. 2014:6749872014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pondugula SR, Dong H and Chen T:
Phosphorylation and protein-protein interactions in PXR-mediated
CYP3A repression. Expert Opin Drug Metab Toxicol. 5:861–873. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chai X, Zeng S and Xie W: Nuclear
receptors PXR and CAR: Implications for drug metabolism regulation,
pharmacogenomics and beyond. Expert Opin Drug Metab Toxicol.
9:253–266. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shah P, Guo T, Moore DD and Ghose R: Role
of constitutive androstane receptor in Toll-like receptor-mediated
regulation of gene expression of hepatic drug-metabolizing enzymes
and transporters. Drug Metab Dispos. 42:172–181. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ghose R, Omoluabi O, Gandhi A, Shah P,
Strohacker K, Carpenter KC, McFarlin B and Guo T: Role of high-fat
diet in regulation of gene expression of drug metabolizing enzymes
and transporters. Life Sci. 89:57–64. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chaouat A, Weitzenblum E, Krieger J,
Ifoundza T, Oswald M and Kessler R: Association of chronic
obstructive pulmonary disease and sleep apnea syndrome. Am J Respir
Crit Care Med. 151:82–86. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tanné F, Gagnadoux F, Chazouillères O,
Fleury B, Wendum D, Lasnier E, Lebeau B, Poupon R and Serfaty L:
Chronic liver injury during obstructive sleep apnea. Hepatology.
41:1290–1296. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Savransky V, Nanayakkara A, Vivero A, Li
J, Bevans S, Smith PL, Torbenson MS and Polotsky VY: Chronic
intermittent hypoxia predisposes to liver injury. Hepatology.
45:1007–1013. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ebert EC: Hypoxic liver injury. Mayo Clin
Proc. 81:1232–1236. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tian JL, Zhang Y and Chen BY: Sleep apnea
hypopnea syndrome and liver injury. Chin Med J (Engl). 123:89–94.
2010.PubMed/NCBI
|
|
32
|
Verbraecken J and McNicholas WT:
Respiratory mechanics and ventilatory control in overlap syndrome
and obesity hypoventilation. Respir Res. 14:1322013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Baeuerle PA and Baltimore D: I kappa B: A
specific inhibitor of the NF-kappa B transcription factor. Science.
242:540–546. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ogura J, Terada Y, Tsujimoto T, Koizumi T,
Kuwayama K, Maruyama H, Fujikawa A, Takaya A, Kobayashi M, Itagaki
S, et al: The decrease in farnesoid X receptor, pregnane X receptor
and constitutive androstane receptor in the liver after intestinal
ischemia-reperfusion. J Pharm Pharm Sci. 15:616–631. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Beigneux AP, Moser AH, Shigenaga JK,
Grunfeld C and Feingold KR: Reduction in cytochrome P-450 enzyme
expression is associated with repression of CAR (constitutive
androstane receptor) and PXR (pregnane X receptor) in mouse liver
during the acute phase response. Biochem Biophys Res Commun.
293:145–149. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gu X, Ke S, Liu D, Sheng T, Thomas PE,
Rabson AB, Gallo MA, Xie W and Tian Y: Role of NF-kappaB in
regulation of PXR-mediated gene expression: A mechanism for the
suppression of cytochrome P-450 3A4 by proinflammatory agents. J
Biol Chem. 281:17882–17889. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang YM, Ong SS, Chai SC and Chen T: Role
of CAR and PXR in xenobiotic sensing and metabolism. Expert Opin
Drug Metab Toxicol. 8:803–817. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen Y, Ferguson SS, Negishi M and
Goldstein JA: Identification of constitutive androstane receptor
and glucocorticoid receptor binding sites in the CYP2C19 promoter.
Mol Pharmacol. 64:316–324. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wortham M, Czerwinski M, He L, Parkinson A
and Wan YJ: Expression of constitutive and rostane receptor,
hepatic nuclear factor 4 alpha and P450 oxidoreductase genes
determines interindividual variability in basal expression and
activity of a broad scope of xenobiotic metabolism genes in the
human liver. Drug Metab Dispos. 35:1700–1710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Aleksunes LM and Klaassen CD: Coordinated
regulation of hepatic phase I and II drug-metabolizing genes and
transporters using AhR-, CAR-, PXR-, PPARα- and Nrf2-null mice.
Drug Metab Dispos. 40:1366–1379. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cai Y, Konishi T, Han G, Campwala KH,
French SW and Wan YJ: The role of hepatocyte RXR alpha in
xenobiotic-sensing nuclear receptor-mediated pathways. Eur J Pharm
Sci. 15:89–96. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Abdulla D, Goralski KB, Del Busto Cano EG
and Renton KW: The signal transduction pathways involved in hepatic
cytochrome P450 regulation in the rat during a
lipopolysaccharide-induced model of central nervous system
inflammation. Drug Metab Dispos. 33:1521–1531. 2005. View Article : Google Scholar : PubMed/NCBI
|
